This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01911/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01911/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB01911/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01911/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01911/identifier/chebi/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01911
rdf:type
n3:Drug
n3:description
N-methylmesoporphyrin is a solid. This compound belongs to the porphyrins. These are compounds containing a fundamental skeleton of four pyrrole nuclei united through the alpha-positions by four methine groups to form a macrocyclic structure. This medication is known to target ferrochelatase.
n3:group
experimental
owl:sameAs
n13:DB01911 n14:DB01911
dcterms:title
N-Methylmesoporphyrin
adms:identifier
n6:46509026 n7:MMP n8:444708 n9:44085 n10:DB01911
n3:IUPAC-Name
n4:271B526E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5274-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5273-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5270-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5271-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5272-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B526C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B526A-363D-11E5-9242-09173F13E4C5 n4:271B526D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B526B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B527A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B527B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5275-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5276-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5278-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5277-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5279-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
142234-85-3
n3:Bioavailability
n4:271B5280-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5282-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5283-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B527F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B527E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5281-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B526F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B527C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B527D-363D-11E5-9242-09173F13E4C5